Redmond Asset Management, LLC Lantern Pharma Inc. Transaction History
Redmond Asset Management, LLC
- $304 Million
- Q1 2024
A detailed history of Redmond Asset Management, LLC transactions in Lantern Pharma Inc. stock. As of the latest transaction made, Redmond Asset Management, LLC holds 40,462 shares of LTRN stock, worth $177,223. This represents 0.12% of its overall portfolio holdings.
Number of Shares
40,462
Previous 40,662
0.49%
Holding current value
$177,223
Previous $174,000
104.6%
% of portfolio
0.12%
Previous 0.06%
Shares
13 transactions
Others Institutions Holding LTRN
# of Institutions
38Shares Held
1.07MCall Options Held
124KPut Options Held
22.2K-
Vanguard Group Inc Valley Forge, PA364KShares$1.59 Million0.0% of portfolio
-
New Edge Advisors, LLC New Orleans, LA161KShares$703,1300.01% of portfolio
-
Geode Capital Management, LLC Boston, MA87.4KShares$382,6980.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny65.7KShares$287,7660.0% of portfolio
-
Cm Management, LLC65KShares$284,7000.5% of portfolio
About Lantern Pharma Inc.
- Ticker LTRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,830,900
- Market Cap $47.4M
- Description
- Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process. Its advanced drug candidate is LP-100, which is in phase II clinical trials to treat metastatic, castration-resistant, and prostate cancer. The company also develops LP-30...